A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis

NCT04948645 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Company Decision

Conditions

ALS
Amyotrophic Lateral Sclerosis

Interventions

DRUG: Fosigotifator
DRUG: Placebo

Sponsor

AbbVie

Collaborators

[object Object]